iTeos Therapeutics, Inc.
ITOS
$7.34
$0.152.09%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 494.65M | 488.71M | 571.26M | 449.14M | 531.92M |
| Total Receivables | 3.69M | 42.80M | 42.35M | 18.92M | 6.50M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 11.20M | 13.36M | 13.00M | 12.32M | 12.24M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 509.54M | 544.88M | 626.61M | 480.39M | 550.65M |
|
|
|||||
| Total Current Assets | 509.54M | 544.88M | 626.61M | 480.39M | 550.65M |
| Net Property, Plant & Equipment | 9.98M | 10.89M | 10.83M | 11.07M | 10.73M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.10M | 7.12M | 6.56M | 5.73M | 5.67M |
| Total Assets | 686.98M | 723.08M | 751.84M | 629.77M | 667.59M |
|
|
|||||
| Total Accounts Payable | 8.50M | 7.15M | 11.06M | 5.53M | 11.29M |
| Total Accrued Expenses | 29.12M | 26.86M | 20.73M | 21.52M | 15.62M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.34M | 1.35M | 1.28M | 1.26M | 1.25M |
| Total Finance Division Other Current Liabilities | 1.40M | 1.45M | 1.60M | 7.24M | 11.85M |
| Total Other Current Liabilities | 1.40M | 1.45M | 1.60M | 7.24M | 11.85M |
| Total Current Liabilities | 40.36M | 36.81M | 34.67M | 35.56M | 40.01M |
|
|
|||||
| Total Current Liabilities | 40.36M | 36.81M | 34.67M | 35.56M | 40.01M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.76M | 4.17M | 4.24M | 4.56M | 4.81M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 52.56M | 50.40M | 49.07M | 48.45M | 47.54M |
| Total Liabilities | 96.68M | 91.39M | 87.97M | 88.57M | 92.36M |
|
|
|||||
| Common Stock & APIC | 616.07M | 608.73M | 601.14M | 471.12M | 463.84M |
| Retained Earnings | -9.78M | 33.93M | 79.29M | 86.42M | 124.63M |
| Treasury Stock & Other | -16.00M | -10.97M | -16.56M | -16.34M | -13.24M |
| Total Common Equity | 590.29M | 631.69M | 663.87M | 541.20M | 575.23M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 590.29M | 631.69M | 663.87M | 541.20M | 575.23M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 590.29M | 631.69M | 663.87M | 541.20M | 575.23M |
|
|
|||||
